News Related to Global X Genomics & Biotechnology ETF

Related coverage linked through entity extraction aliases.

Institutional Investors Adjust Moderna Holdings in Recent Quarter

Mar 12, 2026

Multiple institutional investors modified their Moderna Inc positions during recent quarters, with some funds increasing stakes while others reduced or exited positions, according to 13F filings.

Moderna Settles Legal Dispute with $1.3B Liability as Institutional Investors Adjust Holdings

Mar 04, 2026

Moderna has settled with Arbutus and Genevant, facing a potential $1.3 billion liability contingent on Federal Circuit's decision. Multiple institutional investors have increased their stakes in the biotech company during recent quarters.